

Mini-Monoka®
Mini-Monoka® is indicated for monocanalicular lacerations. It is the gold standard for canalicular repair.
Main characteristics :
• Designed by B. Fayet, M.D. & J.-A. Bernard, M.D.
• FCI exclusive design
• Requires 0.3 mm punctum plug dilator & plug • inserter (S1.3090)
• Option with PVP coating for superior tear drainage
• Sterile, Single use

LacriJet®
LacriJet® is FCI latest and exclusive preloaded & self-retaining monocanalicular nasolacrimal intubation indicated for epiphora, congenital nasolacrimal duct obstruction and canalicular laceration. It consists of a single use injector handpiece into which a silicone tube is preloaded inside a metallic guide. LacriJet® has been specifically designed to reduce operating time, eitherin the intubation phase as well as forthe removal of the device. LacriJet® is first introduced into the nasolacrimal duct. Once in position, the sliding piston is retracted and the silicone intubation is released. It is maintained in place at the punctum by a plug-like fixation head: no nasal retrieval, no knots and no sutures are needed. The smaller sizes LacriJet® 15 mm and 20 mm have been specifically designed for canalicular laceration repair to prevent future canalicular obstruction due to scar tissue formation.
Main characteristics :
• Exclusive new injection system
• Silicone tube preloaded inside the metallic guide
• No nasal retrieval
• No knots
• No sutures
• Available in 7 lengths
• 3 mm plug collarette
• Requires sizer (S1.1288) to select the length & 0.3 mm disposable punctum dilator and plug inserter (S1.3090)
• Sterile, Single use


Masterka®
Masterka® is one of FCI latest innovation for treatment of congenital nasolacrimal duct obstruction resistant to probing. Unlike the traditional “pulled” technique in which the stent is advanced through the nasolacrimal system and retrieved through the nose by pulling on the guide probe or thread, the Masterka® has no metallic probe or suture attached to it and, therefore, it is not pulled out of the nose. Instead, the Masterka® is pushed into the nasolacrimal duct and anchored in place at the punctum by a plug-like fixation head.
Main characteristics :
• Easy to insert
• No nasal retrieval
• No knots
• No sutures
• Less traumatic
• Requires sizer (S1.1289) to select the length & 0.3mm disposable punctumdilator and plug inserter (S1.3090)
• Available in 3 lengths: 30, 35 and 40mm
• 3mmplug collarette
• Medical grade silicone
• Sterile

Monoka®
FCI Monoka® intubation systems have been designed to effectively treat nasolacrimal duct obstructions and canalicular stenosis. The stents are securely anchored at the punctum by a plug-like fixation head.
Main characteristics :
• Designed by B. Fayet, M.D. & J.-A. Bernard, M.D
• 3 mm medium or 4 mm wide plug collarette
• Non-traumatic metallic probe for adults (80mm) and children (60mm)
• Requires 0.3 mm punctum plug dilator & plug inserter (S1.3090)
• Medical grade silicone – PVP option
• Sterile


The Autostable Bicanaliculus Intubation Set ll is indicated to treat punctal stenosis and horizontal lacrimal duct obstruction. Thanks to the rigid guides inside the silicone tube, the placement of the Autostable Bicanaliculus Intubation Set II is straightforward and can be done as an office procedure.
Main characteristics :
• Silicone wings at each end ensure the stability in the lacrimal sac
• Central mark to control tube placement
• Supplied with disposable dilator
• Available in 3 lengths: 25, 30 and 35mm
• Requires sizer (S1.1289) to select the appropriate length
• Medical grade silicone
• Sterile


Ritleng®+ | Autostable Ritleng® Intubation
Ritleng®+ is FCI latest autostable bicanalicular nasolacrimal intubation indicated for epiphora, canalicular pathologies, congenital lacrimal duct obstruction and dacryocystorhinostomy (DCR). It consists of a silicone tube connected at each extremity to a PEEK thread guide. It is designed to reduce operating time and trauma for the patients, either in the intubation phase as well as for the removal of the device. The intubation is self-retaining thanks to two wider silicone portions on the silicone tube. The surgical procedure is similar to the conventional Ritleng® lacrimal intubation and involves the use of Ritleng® instruments.
Main characteristics :
- Regular 0.64 mm silicone tube for a comfortable fit in the intrapalpebral loop
- Wider 0.94 mm silicone segments to be positioned in the lacrimal sac ensuring the self-retaining feature of the intubation: no need to make knots in the nasal fossa
- Blackmark to control the central placement and correct positioning of the silicone tube between the two punctums
- Easy removal from the nose
- Require Ritleng® instruments (S1.1460, S1.1470, S1.1480)
FCI Tüm Oculoplasty Ürünleri için Tıklayınız.